D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells.
Hammon K, Renner K, Althammer M, Voll F, Babl N, Decking SM, Siska PJ, Matos C, Conejo ZEC, Mendes K, Einwag F, Siegmund H, Iberl S, Berger RS, Dettmer K, Schoenmehl R, Brochhausen C, Herr W, Oefner PJ, Rehli M, Thomas S, Kreutz M.
Hammon K, et al. Among authors: siegmund h.
Haematologica. 2024 Aug 1;109(8):2500-2514. doi: 10.3324/haematol.2023.283597.
Haematologica. 2024.
PMID: 38235501
Free PMC article.